National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)’s Post

NIDDK Director Dr. Griffin P. Rodgers joins Michael LeNoir MD from the African American Wellness Project to discuss sickle cell disease and recent advances in its treatment. This is the second topic in a four-part series with AAWP exploring health conditions that impact the African American community. Watch now and follow the series for other episodes on type 2 diabetes, anti-obesity medications, and kidney disease. https://lnkd.in/eNQnFCeD #SickleCellDisease #Hematology 

Each year, Network of Minority Health Research Investigators (NMRI) workshops bring together members of its network for poster presentations, mentorship, and scholarly exchange. The NMRI South Region Workshop will take place in Miami, on October 24-25. Register by October 7 and save your seat. Learn more: https://lnkd.in/e2zRTYJD #NIDDK #NMRI #Mentorship

NIDDK Director Dr. Griffin P. Rodgers is widely recognized for his contributions to the development of the first effective therapy for #SickleCellAnemia, a genetic disorder that affects hemoglobin production and causes red blood cells to be crescent-shaped. The disorder disproportionately affects people of African ancestry. Rodgers was inspired as a child to pursue research into #SickleCellDisease when he saw firsthand the impact it had on his predominately Black community. #SickleCellAwarenessMonth #NIDDK

Happy Postdoc Appreciation Week! We’re grateful for our talented postdocs and their dedication to advancing research and health for all. Learn more about NIDDK’s postdoctoral programs: https://lnkd.in/e_q_2V2i

Did you know that people who exercise regularly are more likely to live longer, healthier lives? Listen to this one-minute #HealthyMoments episode to learn more.

A study partially supported by NIDDK found an elevated risk of developing diabetes after COVID-19 infection, no matter the viral variant and despite the availability of COVID-19 vaccines and treatments. Researchers used National Center for Advancing Translational Sciences (NCATS) National COVID Cohort Collaborative (#N3C) data to look at the risk of developing diabetes at intervals between 180 and 730 days after people were infected with COVID-19. Data was separated by four eras of COVID-19 viral variants: ancestral, Alpha, Delta, and Omicron. The risk of developing diabetes after COVID-19 was similar whether infection occurred during the pandemic’s earlier variants, when COVID-19 was more severe, or later eras when COVID-19 was less severe. The onset of diabetes after infection with Omicron was slower compared to the other three variants. Researchers concluded that we may continue to expect a greater incidence in diabetes in current and future waves of COVID-19, suggesting that diabetes prevention interventions, such as the Diabetes Prevention Program, be incorporated into the standard of care after COVID-19 exposure. Future research is needed to better understand how factors specific to the viral variants and factors such as disease severity, vaccinations, and medications might play a role in promoting or reducing diabetes risk. The current study is available in Diabetes Care, an American Diabetes Association publication. https://lnkd.in/eWVH8S-7

Helping youth manage their health is crucial, especially for those with diabetes. Key focus areas include: 1. Healthy eating 2. Regular activity 3. Mental health 4. Consistent monitoring Learn more about managing diabetes in youth on the Diabetes Discoveries & Practice Blog: https://lnkd.in/e7v7tVHk

Are you a recent college graduate looking to start your career in biomedical research? NIDDK is now accepting applications for its Distinguished Postbaccalaureate Scholars Program! The program offers one or two years of hands-on research experience, mentorship, and stipend to help you achieve your goals. Whether your research interests are diabetes, digestive diseases, or kidney health, this program can help you make a difference. 🎯 Applications are due Dec. 6. Learn more and apply: https://lnkd.in/eDD4KYaW #NIDDK #Postbac #ResearchCareer #BiomedicalResearch #CareerDevelopment

Research funded in part by NIDDK shows that, in people with type 2 diabetes, use of the prescription drug metformin is linked to a lower risk of developing long COVID or dying after COVID-19 infection. #LongCOVID #Research #Type2Diabetes

September is Polycystic Ovary Syndrome (PCOS) Awareness Month. Dr. Andrea Dunaif of Icahn School of Medicine at Mount Sinai spotlights research about PCOS and how it affects women with diabetes on the Diabetes Discoveries & Practice Blog.